Cargando…

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Detalles Bibliográficos
Autores principales: Peakman, Mark, von Herrath, Matthias
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927927/
https://www.ncbi.nlm.nih.gov/pubmed/20805382
http://dx.doi.org/10.2337/db10-0630
_version_ 1782185800284241920
author Peakman, Mark
von Herrath, Matthias
author_facet Peakman, Mark
von Herrath, Matthias
author_sort Peakman, Mark
collection PubMed
description
format Text
id pubmed-2927927
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-29279272011-09-01 Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential Peakman, Mark von Herrath, Matthias Diabetes Perspectives in Diabetes American Diabetes Association 2010-09 /pmc/articles/PMC2927927/ /pubmed/20805382 http://dx.doi.org/10.2337/db10-0630 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Perspectives in Diabetes
Peakman, Mark
von Herrath, Matthias
Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
title Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
title_full Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
title_fullStr Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
title_full_unstemmed Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
title_short Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
title_sort antigen-specific immunotherapy for type 1 diabetes: maximizing the potential
topic Perspectives in Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927927/
https://www.ncbi.nlm.nih.gov/pubmed/20805382
http://dx.doi.org/10.2337/db10-0630
work_keys_str_mv AT peakmanmark antigenspecificimmunotherapyfortype1diabetesmaximizingthepotential
AT vonherrathmatthias antigenspecificimmunotherapyfortype1diabetesmaximizingthepotential